139 related articles for article (PubMed ID: 9013644)
1. Degradation of E2A proteins through a ubiquitin-conjugating enzyme, UbcE2A.
Kho CJ; Huggins GS; Endege WO; Hsieh CM; Lee ME; Haber E
J Biol Chem; 1997 Feb; 272(6):3845-51. PubMed ID: 9013644
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the mUBC9-binding sites required for E2A protein degradation.
Huggins GS; Chin MT; Sibinga NE; Lee SL; Haber E; Lee ME
J Biol Chem; 1999 Oct; 274(40):28690-6. PubMed ID: 10497239
[TBL] [Abstract][Full Text] [Related]
3. The mUBC9 murine ubiquitin conjugating enzyme interacts with the E2A transcription factors.
Loveys DA; Streiff MB; Schaefer TS; Kato GJ
Gene; 1997 Nov; 201(1-2):169-77. PubMed ID: 9409784
[TBL] [Abstract][Full Text] [Related]
4. Bridge-1, a novel PDZ-domain coactivator of E2A-mediated regulation of insulin gene transcription.
Thomas MK; Yao KM; Tenser MS; Wong GG; Habener JF
Mol Cell Biol; 1999 Dec; 19(12):8492-504. PubMed ID: 10567574
[TBL] [Abstract][Full Text] [Related]
5. Human Cdc34 and Rad6B ubiquitin-conjugating enzymes target repressors of cyclic AMP-induced transcription for proteolysis.
Pati D; Meistrich ML; Plon SE
Mol Cell Biol; 1999 Jul; 19(7):5001-13. PubMed ID: 10373550
[TBL] [Abstract][Full Text] [Related]
6. The polymyositis-scleroderma autoantigen interacts with the helix-loop-helix proteins E12 and E47.
Kho CJ; Huggins GS; Endege WO; Patterson C; Jain MK; Lee ME; Haber E
J Biol Chem; 1997 May; 272(20):13426-31. PubMed ID: 9148967
[TBL] [Abstract][Full Text] [Related]
7. Notch-induced E2A degradation requires CHIP and Hsc70 as novel facilitators of ubiquitination.
Huang Z; Nie L; Xu M; Sun XH
Mol Cell Biol; 2004 Oct; 24(20):8951-62. PubMed ID: 15456869
[TBL] [Abstract][Full Text] [Related]
8. Association of activating transcription factor 2 (ATF2) with the ubiquitin-conjugating enzyme hUBC9. Implication of the ubiquitin/proteasome pathway in regulation of ATF2 in T cells.
Firestein R; Feuerstein N
J Biol Chem; 1998 Mar; 273(10):5892-902. PubMed ID: 9488727
[TBL] [Abstract][Full Text] [Related]
9. Catabolite inactivation of fructose-1,6-bisphosphatase of Saccharomyces cerevisiae. Degradation occurs via the ubiquitin pathway.
Schork SM; Thumm M; Wolf DH
J Biol Chem; 1995 Nov; 270(44):26446-50. PubMed ID: 7592860
[TBL] [Abstract][Full Text] [Related]
10. Kip1 degradation via the ubiquitin-proteasome pathway.
Tam SW; Theodoras AM; Pagano M
Leukemia; 1997 Apr; 11 Suppl 3():363-6. PubMed ID: 9209391
[TBL] [Abstract][Full Text] [Related]
11. A yeast Ubc9 mutant protein with temperature-sensitive in vivo function is subject to conditional proteolysis by a ubiquitin- and proteasome-dependent pathway.
Betting J; Seufert W
J Biol Chem; 1996 Oct; 271(42):25790-6. PubMed ID: 8824207
[TBL] [Abstract][Full Text] [Related]
12. Glucose activation of the yeast plasma membrane H+-ATPase requires the ubiquitin-proteasome proteolytic pathway.
de la Fuente N; Maldonado AM; Portillo F
FEBS Lett; 1997 Jul; 411(2-3):308-12. PubMed ID: 9271226
[TBL] [Abstract][Full Text] [Related]
13. ER degradation of a misfolded luminal protein by the cytosolic ubiquitin-proteasome pathway.
Hiller MM; Finger A; Schweiger M; Wolf DH
Science; 1996 Sep; 273(5282):1725-8. PubMed ID: 8781238
[TBL] [Abstract][Full Text] [Related]
14. An essential domain within Cdc34p is required for binding to a complex containing Cdc4p and Cdc53p in Saccharomyces cerevisiae.
Mathias N; Steussy CN; Goebl MG
J Biol Chem; 1998 Feb; 273(7):4040-5. PubMed ID: 9461595
[TBL] [Abstract][Full Text] [Related]
15. Degradation of Id proteins by the ubiquitin-proteasome pathway.
Bounpheng MA; Dimas JJ; Dodds SG; Christy BA
FASEB J; 1999 Dec; 13(15):2257-64. PubMed ID: 10593873
[TBL] [Abstract][Full Text] [Related]
16. Interaction of the ring finger-related U-box motif of a nuclear dot protein with ubiquitin-conjugating enzymes.
Pringa E; Martinez-Noel G; Muller U; Harbers K
J Biol Chem; 2001 Jun; 276(22):19617-23. PubMed ID: 11274149
[TBL] [Abstract][Full Text] [Related]
17. Helix-loop-helix proteins LYL1 and E2a form heterodimeric complexes with distinctive DNA-binding properties in hematolymphoid cells.
Miyamoto A; Cui X; Naumovski L; Cleary ML
Mol Cell Biol; 1996 May; 16(5):2394-401. PubMed ID: 8628307
[TBL] [Abstract][Full Text] [Related]
18. Regulation of STRA13 by the von Hippel-Lindau tumor suppressor protein, hypoxia, and the UBC9/ubiquitin proteasome degradation pathway.
Ivanova AV; Ivanov SV; Danilkovitch-Miagkova A; Lerman MI
J Biol Chem; 2001 May; 276(18):15306-15. PubMed ID: 11278694
[TBL] [Abstract][Full Text] [Related]
19. The Saccharomyces cerevisiae ubiquitin-proteasome system.
Hochstrasser M; Johnson PR; Arendt CS; Amerik AYu ; Swaminathan S; Swanson R; Li SJ; Laney J; Pals-Rylaarsdam R; Nowak J; Connerly PL
Philos Trans R Soc Lond B Biol Sci; 1999 Sep; 354(1389):1513-22. PubMed ID: 10582237
[TBL] [Abstract][Full Text] [Related]
20. Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathway.
Alkalay I; Yaron A; Hatzubai A; Orian A; Ciechanover A; Ben-Neriah Y
Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10599-603. PubMed ID: 7479848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
